It fails when organisations treat third-party access as outside the core identity model. Under HIPAA Omnibus, business associates and subcontractors are part of the governed chain, so access that lacks ownership, purpose scoping, and revocation evidence becomes a compliance exposure rather than a routine operational permission.
Where the governance failure actually starts
PHI access governance fails first at the boundary where a business associate is treated as “outside” the core identity and access model. In practice, the governed chain includes the covered entity, the business associate, and any subcontractors handling PHI on its behalf. Once that chain is not owned end to end, access reviews, purpose scoping, and revocation become incomplete by design.
The common breakdown is not just excessive access, but unclear accountability. If a third party can reach PHI through a shared integration, delegated admin path, or stale entitlement, the organisation may still believe the control exists because a contract exists. The real governance question is whether there is a named owner, a defined purpose, and evidence that access was removed when the relationship or task ended.
That is why the failure point is often lifecycle control rather than the initial grant. Access that is granted for onboarding but never recertified, narrowed, or formally revoked becomes residual exposure. For healthcare environments, the distinction matters because PHI access is not simply operational convenience, it is a regulated trust relationship that must remain observable over time.
Why third-party access becomes a compliance problem
Third-party access becomes a compliance problem when it is managed as vendor risk only, instead of as governed access to sensitive data. Under HIPAA Omnibus, business associates are not outside the control plane, they are part of it. That means the same discipline expected for internal users, ownership, least privilege, and deprovisioning must extend to third parties and downstream subcontractors.
The practical requirement is not to “trust the contract” but to prove control over who can see PHI, why they can see it, and when that access ends. If purpose scoping is missing, access tends to accumulate around convenience, exceptions, and operational urgency. If revocation evidence is missing, the organisation cannot show that access was actually removed after the business need ended.
Access governance therefore fails when it stops at procurement, legal review, or onboarding workflow completion. The security and compliance exposure appears later, when access persists beyond the approved purpose, the responsible owner cannot attest to current necessity, or subcontractor access is never brought into the review cycle.
What to look for in a broken control chain
A broken control chain usually has the same few symptoms: no authoritative inventory of third-party accounts, no clear link between access and a business purpose, and no periodic review that includes both the business associate and its subcontractors. The issue is usually not a missing policy statement, it is the absence of operational evidence that the policy is being enforced.
For readers trying to diagnose the gap, the key indicator is whether you can answer three questions at once: who owns the access, what PHI purpose justifies it, and what proves the access was removed when no longer needed. If any one of those answers is vague, the governance model is already weak.
For broader access-governance patterns, the failure mode is the same one that shows up in IAM and IGA Basics, where entitlement review and third-party access management must be handled as part of the same control plane. The lifecycle risk becomes harder to miss when teams use a structured review process like Access Reviews and Certification Guide and make removal evidence part of the approval record. For healthcare-specific exposure, Healthcare Identity Security Guide ties these governance failures to PHI, third parties, and shared access paths.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-53 Rev 5 and CIS Controls v8 set the technical controls, while ISO/IEC 27001:2022 and SOC 2 (AICPA) define the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-53 Rev 5 | AC-20 — Use of External Information Systems | Business associate PHI access is third-party access that needs explicit external-use control. |
| AC-6 — Least Privilege | PHI access governance fails when third parties retain more access than their purpose requires. | |
| IA-5 — Authenticator Management | External PHI access depends on controlled credential issuance, rotation, and revocation. | |
| Recommendation — Limit external-system access to PHI with approved conditions and monitoring. Restrict business associate access to the minimum PHI needed for the approved task. Manage third-party credentials so PHI access can be revoked promptly and verifiably. | ||
| ISO/IEC 27001:2022 | A.5.18 — Access rights | PHI governance hinges on granting, reviewing, and removing third-party access rights. |
| A.5.19 — Information security in supplier relationships | Business associates are supplier relationships that must be governed for PHI access. | |
| A.5.20 — Addressing information security within supplier agreements | HIPAA business associate expectations need clear contractual security obligations. | |
| Recommendation — Review and revoke external PHI access rights on a defined lifecycle. Set supplier access requirements for PHI, review them, and enforce them contractually and operationally. Define PHI access, revocation, and evidence requirements in supplier agreements. | ||
| CIS Controls v8 | CIS-6 — Access Control Management | Third-party PHI access is an access-control problem with ownership and revocation needs. |
| CIS-5 — Account Management | External accounts must be tracked and removed when the business need ends. | |
| Recommendation — Centralise and continuously manage business associate access to PHI. Inventory, review, and disable third-party accounts that can reach PHI. | ||
| SOC 2 (AICPA) | CC6.1 — Logical and Physical Access Controls | Vendor PHI access must be restricted and reviewed to satisfy access-control expectations. |
| Recommendation — Restrict third-party access to PHI and review entitlements periodically. | ||
Practitioner Guidance
What to prioritise: Start with the third-party inventory, not the access request queue. If you cannot enumerate every business associate and subcontractor account that can reach PHI, you cannot govern the access meaningfully.
What to verify: Verify that every external PHI entitlement has a named business owner, a documented purpose, and a revocation trigger tied to contract end, task completion, or risk escalation. If you cannot produce removal evidence, treat the access as still active.
Common mistake: Do not let contract language substitute for technical control. A signed agreement does not prove least privilege, does not prove recertification, and does not prove deprovisioning.
Practitioner takeaway: The control fails when third-party PHI access is governed as a vendor relationship instead of as a living identity and entitlement problem with ownership, purpose, and offboarding evidence.
Related resources from NHI Mgmt Group
- What is the difference between role-based access and API key governance for NHI security?
- How should healthcare organisations govern access to PHI across business associates?
- Who should own access governance when multiple business systems are involved?
- What should healthcare organizations do first when business associates need access to EMR or PHI?